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Abstract
Familial Danish Dementia (FDD) is an autosomal disease, which is distinguished by gradual loss of vision, deafness,
progressive ataxia and dementia. Cataract is the first manifestation of the disease. In this article, we demonstrate a specific
correlation between the poisoning of the chaperone activity of the rat eye lens a-crystallins, loss of lens transparency in
organ culture by the pathogenic form of the Danish dementia peptide, i.e. the reduced Danish dementia peptide (redADan
peptide), by a combination of ex vivo, in vitro, biophysical and biochemical techniques. The interaction of redADan peptide
and lens crystallins are very specific when compared with another chaperone, HSP-70, underscoring the specificity of the
pathogenic form of Danish dementia peptide, redADan, for the early onset of cataract in this disease.
Citation: Surolia I, Sinha S, Sarkar DP, Reddy PY, Reddy GB, et al. (2008) Concurrence of Danish Dementia and Cataract: Insights from the Interactions of Dementia
Associated Peptides with Eye Lens a-Crystallin. PLoS ONE 3(8): e2927. doi:10.1371/journal.pone.0002927
Editor: Edathara Abraham, University of Arkansas for Medical Sciences, United States of America
Received June 23, 2008; Accepted July 14, 2008; Published August 13, 2008
Copyright:  2008 Surolia et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work is supported by grants from the Dept. of Biotechnology, Government of India, and from the Department of Science and Technology,
Government of India, to AS.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: surolia@nii.res.in
. These authors contributed equally to this work.
Introduction
With the rise in the average age of population, neurodegener-
ative diseases are becoming increasingly common resulting in a
greater burden on the healthcare system of most countries. Many
of these perplexing disorders are known to arise from the
conformational instability resulting in misfolding of an underlying
protein [1,2]. The consequence is a continuum of pathologies with
typically a change in fold leading to ordered aggregation and tissue
deposition. Conformational diseases arise when a constituent
protein undergoes a change in size or fluctuation in shape, with
resultant self-association and tissue deposition. Normally, these
deposits are b-pleated sheets with distinct morphological features
and, once formed, mostly remain unperturbed. Although such
changes can occur with normal proteins, there is commonly an
interacting genetic contribution, which may sometimes be a
dominant determinant. Many of these proteins have critical roles
in signaling and cell cycle control, which are perhaps responsible
for their enormous impact on human health. There are at least a
dozen of diseases known to arise due to protein misfolding or
aggregation, which have devastating medical and social conse-
quences [3].
Diseases such as Alzheimer’s, Parkinson’s and Mad cow have a
number of pathological symptoms. The two familial amyloidoses,
viz familial British and Danish dementias (FBD and FDD), are the
two neurodegenerative disorders which are linked to different
genetic defects in the same gene, BRI. Histological signatures of
FDD are cerebral amyloid angiopathy, parenchymal protein
deposits and neurofibrillary degeneration [4]. The 34 amino acid
Danish dementia (ADan) peptide is thought to be the major cause
of amyloid deposition in brains of patients suffering from FDD,
whereas a 34-amino acid-long ABri peptide is believed to be the
culprit of FBD. While they originate from different genetic defects
in the BRI gene, ADan and ABri peptides have a number of
common features. The amyloid precursor proteins in the British
family (ABriPP) and in the Danish family (ADanPP) have the same
length of 277 amino acids. Also, both the peptides have the same
sequence length and share identical N-terminal amino acid
sequence (the first 22 residues), which suggests that these molecules
are generated by the same proteolytic mechanism [4]. Earlier
reports on ADan peptides have shown that both the oxidized
(oxAdan; Cys5 and Cys22 linked by an intramolecular disulfide
bond) and the reduced (redAdan; no intramolecular disulfide bond
present) forms of the peptide are incompetent in producing fibers
at pH 7.0 [5]. However, we demonstrated that, the morphology of
the aggregates formed depends greatly on the form of the peptide
(viz. the oxidized versus the reduced peptide) [6]. We also reported
that the neurotoxicity of the reduced form is greater than that of
the oxidized form [6,7].
FDD is also known as heredo-oto ophthalmo-encephlopathy
(HOOE). HOOE/FDD is a dominantly inherited syndrome
clinically characterized by a gradual loss of vision, deafness,
progressive ataxia and dementia [8,9]. Visual loss in FDD is
caused by posterior subcapsular cataract and retinal neovascular-
ization. Cataracts seem to be the earliest manifestation of this
disease, starting at the age of 20 followed by hearing impairment
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developing at the age of 40. Cerebellar ataxia then follows and
consequently symptoms of paranoid psychosis and dementia are
observed [10]. Early-onset of cataract is also seen in Alzheimer’s
and Down syndrome patients [11].
Cataract, characterized by cloudiness or opafication of the eye
lens, is the leading cause of blindness all over the world. Crystallins
are the major structural proteins in the lens accounting for up to
90% of total soluble protein. There are three distinct families of
crystallins: a-, b- and c-crystallins, whose structure, stability and
short-range interactions are thought to contribute to the lens
transparency [12]. The human lens is also susceptible to age-
related degenerative changes such as accumulation of insoluble
proteins and oxidative damage and hence senile cataracts are the
most common form of the cataract [12,13]. a-Crystallin, a
member of the small heat shock protein family, constitutes a
major portion of the eye lens cytoplasm. It constitutes up to 50%
of the total protein [14,15,16,17]. a-Crystallin monomer has Mr.
of 20,000. In humans, lenticular a-crystallin exists as a hetero-
oligomer of approximately Mr. 800,000 with two subunits, aA and
aB occurring in a stoichiometry of 3:1 [16]. aA-Crystallin appears
to be largely lens-specific, whereas aB-crystallin is also expressed in
other tissues such as heart, skeletal muscle, kidney, and brain.
Increased levels of aB-crystallin have been observed in many
neurodegenerative disorders, tumors and diabetic conditions
[18,19]. Both of these proteins are known for their chaperone
activity as evident from suppression of protein aggregation. Thus
they presumably protect other lens proteins from the adverse
effects of heat, chemicals, and UV light irradiation. It is widely
acknowledged that with aging eye lens proteins undergo various
posttranslational modifications, most of which lead to aggregation
and this process is further accelerated due to various physiological,
environmental and genetic factors that predispose lens to cataract
formation [12,13]. Hence, in addition to providing refractive
properties to the eye lens, a-crystallins are instrumental in
maintaining transparency of the lens with their chaperone-like
activity [12,20,21]. Recently it has been reported that some low
molecular weight peptides found in aged and cataractous lens bind
and reduce the chaperone activity of a-crystallin [22].
This article addresses the relationship between cataract and
Danish dementia, which is unique among amyloid disorders as its
earliest manifestation involves cataract. As a-crystallin plays a
pivotal role in maintaining the lens transparency and its damage is
reported to play a major casual role in cataracts [23,24] we have
probed the interaction of the Danish dementia and some other
dementia associated peptides with the lens a-crystallin in vitro and
ex vivo. Our studies demonstrate that ADan reduced peptide
(redADan) has both exquisite specificity and ability among several
amyliodogenic peptides to compromise the chaperonic function of
a-crystallin as well disposing lens in organ culture to cataractogen-
esis all of which help explain the high incidence of the occurrence
of cataract in Danish dementia.
Results
Changes in lens morphology upon interaction of the
ADan, ABri and Ab peptides:
Initial studies with redADan showed that lenses incubated for
four consecutive days with 10 mM redADan peptide concentration
became cloudy and lost transparency completely (Figure 1a).
Hence, the effect of the various dementia-associated peptides on
the opafication of lenses was studied at 10 mM concentration.
However, at this concentration oxADan peptide or redABri
peptides did not affect lens transparency to any appreciable extent
[Figure 1b]. Also lenses incubated with 10 mM of oxABri or Ab-40
peptide exhibited a partial opafication only. This opafication is
close to 50% of that observed with the redADan peptide [Figure 1].
Effect of the ADan, ABri and Ab peptides on the
chaperone activity of a-crystallins:
The poisoning of chaperone activity of crystallins in the
presence of these peptides was monitored by the heat induced
citrate synthase aggregation and DTT-induced insulin aggregation
profiles (Figure 2) [19,25]. It was observed that the peptides were
poisoning to a variable extent the chaperone activities of the a-
crystallins, aA and aB. While in the case of redADan the
poisoning was most remarkable, the other peptides exhibited less
poisoning of the chaperone activity. Thus at equimolar concen-
trations of ADan there was almost 80% poisoning of the
chaperone activity of aA-crystallin. About 50% and 30%
poisoning was observed when redADan: aA-crystallin were used
in the ratios of 1:2 and 1:4 respectively (Figure 2a). Moreover,
almost 100% poisoning of aA-crystallin was obtained when the
ratio of redADan used was 5:1 and 10:1. On the other hand, Ab-
40 peptide and oxABri accounted for only ,30% of the poisoning
at equimolar concentration of aA-crystallin. Interestingly, only
10% loss of the chaperone activity of aA-crystallin, at equimolar
concentrations of redABri and oxADan peptides was observed
(Figure 2b). Similar results were observed with insulin aggregation
assays for aA- crystallin (Figure 2c). The effect of different
concentrations of the dementia peptides on the chaperone activity
of aA-crystallin was also studied. Increasing the concentrations of
oxABri, redABri and oxADan to 10 times the aA-crystallin
concentration did not show any marked difference in the
poisoning of the chaperone activity of the crystallin compared to
the equimolar situation for oxABri, redABri and oxADan.
However, under similar conditions the chaperone activity was
compromised to the extent of 60 % by the Ab-40 peptide
(Figure 3).
The chaperone activity of aB-crystallin at an equimolar
concentration of redADan was compromised slightly more
(,90%) over that observed for aA-counterpart which is not
surprising in view of the previous observations about the relative
activities of these crystallin isoforms ( Figure S1). Similar results
were observed with insulin aggregation assays for aA-crystallin
(Figure 2c). Due to the relative abundance of aA form of crystallin
in both the human & rat eye lenses, unless otherwise stated, most
of our studies reported here were carried out with aA-crystallin.
Chaperone activity of the a-crystallin isolated from rat
lenses incubated with the peptides:
While, aL-crystallin isolated from the rat lenses treated with
redADan showed significantly (48%) decreased chaperone activity
as compared to aL-crystallin isolated from untreated lenses in
citrate synthase aggregation assay. In comparison, the reduction in
chaperone activity of aL-crystallin isolated from lenses treated
with Ab-40 peptide, oxABri, redABri and oxAdan was 39%, 36%,
31% and 27% respectively.
Changes in lens protein content upon interaction of the
ADan, ABri and Ab peptides:
Generally lens opafication or cataract is associated with
insolubilization of otherwise soluble lens proteins. Therefore,
estimation of the protein content in both the soluble and insoluble
fractions of the lens extract (homogenate) was done. Insolubliza-
tion of soluble protein in the redADan treated lenses was
remarkably high as the percent soluble fraction was reduced to
48% compared to 81% in control lenses [Table 1]. The reduction
Danish Dementia and Cataract
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in soluble protein content in the soluble fraction of lenses treated
with oxADan, redABri, Ab-40 and oxABri was 69%, 70% 67%
and 64% respectively. Thus the lenses treated with the redADan
peptide yielded the least amount of soluble protein in the soluble
fraction (Table 1).
Determination of dissociation constants for the
interactions of a-crystallins with ADan, ABri and Ab
peptides:
The dissociation constants (Kd) for the interaction of the five
dementia associated peptides with a2crystallins presented very
interesting results. While Ab-40 peptide demonstrated nanomolar
range dissociation constant, the Kd values for the interaction of the
other peptides with both a-crystallins were in the micromolar
range. Our results corroborate well with an earlier report on the
binding of a-crystallins to Ab-peptide [11]. Isothermal Titration
Calorimetric (ITC) binding studies were also done with redADan
peptide and aA-crystallin. The value of the Kd obtained from the
nonlinear least squares fit of the data is ,1.7 mM (Figure S2),
which is in close proximity to the values obtained spectroscopically
for redADan aA-crystallin association viz. 2.7 mM. However, the
ITC fit obtained has a high x2 value perhaps due to the
aggregation of the peptides in solution at the concentrations
required for ITC studies. Hence, ITC was not used for further
studies. The dissociation constants obtained using the spectropho-
tometric assay of these peptides binding to both aA-crystallin and
aB-crystallin are presented in Figure 4 and the corresponding Kd
values are listed in Table 2. The Kd shows the following trend:
Ab240 peptide .redADan.oxABri.redABri,oxADan.
However, the trend in the loss of chaperone activity of a-
crystallin does not parallel the trend of binding affinities exhibited
by these peptides for this chaperone. This suggests that the affinity
of interaction (viz the dissociation constant) between the crystallins
& the dementia peptides do not correspond strictly with their
pathogenic effects in the organ culture, pointing towards specificity
in catractogenesis caused by redADan. Significantly, redADan
also exhibits greatest potency in inhibiting chaperone activity of
both aA and aB-crystallin.
ANS binding studies
Further, to probe the nature of interaction between a-crystallin
and the dementia associated peptides, 8-anilino-1-napthalenesul-
fonic acid (ANS) was used to measure the extent of hydrophobic
surface of aA-crystallin in the presence and absence of redADan
and the other peptides used in this study. While a considerable
decrease in the intensity at 470 nm for ANS complexed to aA-
Crystallin occurs in the presence of redADan peptide (80%), other
Figure 1. Opafication of lenses from adult Wistar rats cultured in TC-199 medium with and without dementia related peptides. (A)
Opafication of rat lenses cultured with 0 mM (a), 5 mM (b), 10 mM (c) & 25 mM (d) redADan peptide. TC-199 medium was changed every 24 h. At 96 h
the lenses were evaluated for their opafication as described in the method. (B). In each case 10 mM of the peptide with a rat lens in the culture
medium was used and the peptide containing medium was changed every 24 h. At 96 h the lenses were processed for evaluating their opafication as
described in the text. a: Control Lens; b: redAdan; c: oxAdan; d: redABri; e: oxABri and f: Ab-40 peptide.
doi:10.1371/journal.pone.0002927.g001
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dementia associated peptides compromised in a feeble manner the
fluorescence of ANS complexed to this chaperone. Thus, in the
presence of Ab-40 the fluorescence intensity was diminished by
55%, while, redABri and oxAbri account for ,33% loss in the
fluorescence intensity. For oxADan the decrease in ANS
fluorescence was only 11% (Figure 5).
Discussions
Previous studies from our laboratory have shown that while
oxADan peptide give rise to fibrils that are stable and birefringent,
redADan yields only dome shaped non-birefringent intermediates
[6]. Nevertheless, it is the early oligomers of redADan that are
much more effective in neuropathogenesis as assayed by MTT
assay at lower concentrations than those of oxADan counterparts
[6,7]. In ABri peptides, oxABri not only leads to fibril formation
but also constitutes the toxic form unlike its reduced counterpart,
redABri. Early age lens cataract is a significant pathological
signature of Danish dementia [8]. This article sheds light on the
issue of the relationship between Danish dementia and eye lens
cataract. For this purpose we initially probed the interaction of a-
crystallin with ADan, ABri and Ab-40 peptides employing a
number of in vitro and ex vivo techniques. Results of our study show
that out of the five genres of peptides examined here, the redADan
is most instrumental in rendering rat lenses opaque. Ab-peptide
and oxABri peptides show in comparison a considerably reduced
extent of lens opafication. RedABri and oxADan on the other
hand show a remarkably reduced loss of transparency of the
lenses. Our studies thus indicate as to why redADan (the
pathogenic form of Danish dementia peptide) displays the striking
hallmark viz. cataract, often intimately linked with the earliest
symptoms of Danish dementia [5,6,26].
OxADan and redABri peptides show relatively low binding
constants to a-crystallin while compromising its chaperone activity
marginally only. Moreover, they were also poor in inducing
opafication of lenses in organ culture. However, the reason as to
why oxABri peptide also showed inhibition of the chaperone
activity of a-crystallin is somewhat unclear. One of the reasons
may be related to the fact that a-crystallin has exposed
hydrophobic sites which may provide a surface for a non-specific
Figure 2. (a) Chaperone activity of aA-crystallin as assessed by the suppression of heat induced aggregation of citrate synthase in the presence of
different concentrations of redADan peptides. Citrate Synthase (0.05 mg/ml) was incubated in the absence (black) or presence of 10 mM a-crystallin
(dark blue), or lenses treated with 2.5 mM redADan (light blue), 5 mM redADan (green), 10 mM redADan (red), 20 mM redADan (pink), 50 mM redADan
(yellow) and 100 mM redADan (brown) (b) Chaperone activity of aA-crystallin (10 mM) as assessed by the suppression of heat induced aggregation of
citrate synthase (0.05 mg/ml) at 43uC in the presence of dementia related peptides (dark blue) redAbri, (pink) oxADan, (light blue) oxAbri, (yellow) Ab-
40, (green) redADan (10 mM of each of the peptides). (c) Chaperone activity of aA-crystallin as assessed by the suppression of DTT induced
aggregation of insulin. Insulin was incubated in the absence (black) and presence of 10 mM a-crystallin (red), oxADan (green) and redADan (yellow)
peptides (Insulin, 0.2 mg/ml; DTT, 20 mM at pH 7.2) (d) Chaperone activity of aL-crystallin as assessed by the suppression of heat induced
aggregation of citrate synthase at 43uC. Citrate synthase, 0.05 mg/ml, was then incubated in the absence (black) or presence of 10 mM a-crystallin
isolated from control lenses (red), or lenses treated with oxAdan (yellow), redABri (pink), Ab240 peptide (light blue), oxABri (dark blue) and redAdan
(light green).
doi:10.1371/journal.pone.0002927.g002
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association of oxABri which is known to aggregate rapidly. Thus
the effect of oxABri may be a secondary event which may be
related to nonspecific factors such as cross-linking and consequent
aggregation of the lens proteins. This indeed appears to be the case
in the light of the data discussed below.
Since inhibition of the chaperone activity of lens crystallins is
primarily shown to be responsible for the ease and specificity with
which redADan manifests appearance of cataract in lens organ
culture, we also studied the effect of redADan on another
chaperone. For this purpose the efficacy of redADan and other
dementia related peptides on the chaperone function of human
HSP-70 was examined [27]. None of the dementia peptides
compromise in any significant manner the activity of HSP-70
(Figure S3). This is significant as it shows that the interaction of the
redADan peptide with the a-crystallin and the subsequent loss of
the chaperone activity of the latter are very specific which underlie
cataract, one of the hallmarks of the pathogenesis observed in
Danish dementia.
As the structure of a-crystallin is not available it becomes a bit
difficult to point out the exact sites in it that may be interacting
with these dementia-associated peptides. The exposure of
hydrophobic surface on a-crystallins is intrinsic to their chaperone
functions. Hence, the exposure of hydrophobic surface on the free
aA-crystallin and the aA-crystallin complexed to the dementia
associated peptides was probed with ANS. OxADan, redABri and
oxABri show 10–35% reduction in ANS fluorescence. Ab-40
Figure 3. Chaperone activity of aA-crystallin (10 mM) as assessed by the suppression of heat induced aggregation of citrate
synthase (0.05 mg/ml) at 43uC in the presence of different concentrations of (a) oxADan (b) Ab-40 peptide (c) oxABri(d) redABri.
[black: citrate synthase; red: citrate Synthase + aA-crystallin; dark blue: citrate Synthase + Dememtia peptide : aA-crystallin (1:1); green: citrate
Synthase + Dememtia peptide: aA-crystallin (2:1); light blue: citrate Synthase + Dememtia peptide: aA-crystallin (10:1)].
doi:10.1371/journal.pone.0002927.g003
Table 1. Effect of peptides on lens protein content in rat lens
Parameter Control redAdan oxAdan redABri oxABri Ab (1–42)
Total protein (mg/g lens) 518 483 485 496 456 464
Soluble protein (mg/g lens) 421 232 338 346 292 310
Insoluble protein (mg/g lens) 95 240 135 141 150 145
% Soluble protein a 81 48 70 70 64 67
aPercentage soluble protein is calculated in relation to the amount of total protein
doi:10.1371/journal.pone.0002927.t001
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peptide exhibits 45–55% reduction in fluorescence of ANS
complexed to aA-crystallin as compared to 80% loss observed in
the presence of redADan. The fact that oxABri compromises in a
feeble manner the fluorescence of ANS-aA-crystallin complex
lends support to our interpretation in general about the non-
specificity of the affect of oxABri on lens opafication. Hence, the
poisoning of the chaperone activity of a cystallins by redADan and
Ab-40 peptide and their strong affinities for binding to crystallins
are consistent with the observed loss of the exposed hydrophobic
areas on its surface. This in turn is consistent with the greater
potencies of redADan and Ab-40 peptide in rendering the lenses
opaque as demonstrated in these studies.
In conclusion, our studies show a remarkable correlation
between the ability of redADan peptide to incapacitate the
chaperone activity of a-crystallin in vitro with its ability to cause
opafication of eye lenses ex-vivo. Other dementia related peptide
despite their established role in amyloid diseases, exhibit relatively
poor inhibition of the chaperone function of eye lens crystallins as
well as considerably reduced opafication of lenses in organ culture
as compared to the redADan explaining as to why in FDD alone
among the amyloid diseases an early onset of cataract is observed.
These results provide a mechanistic basis for the dominant
HOOE/FDD syndrome viz. the poisoning of chaperone-like
function of a-crystallins. Studies that report the role of a -crystallin
in other neurodegenerative conditions support this possibility. For
example, Ab-40 peptide is known to be expressed in rodent and
Figure 4. Spectrophotometric determination of the dissociation constant for the interaction of a-crystallin (A and B) with (a)
redADan (b)oxADan (c)oxABri (d) redABri (e)Ab-40 peptide.
doi:10.1371/journal.pone.0002927.g004
Table 2. Dissociation constants (Kd) of a-crystallins with
peptides at 25uC
Peptides aA-crystallin aB-crystallin
Ab-40 56.96102964.261029 M 184.861029614.761029 M
RedADan 2.76102661.8261027 M 4.16102661.9461026 M
OxADan 6.506102565.4361026 M 2.126102461.95261025 M
RedABri 1.76102461.661025 M 2.56102463.161025 M
OxABri 17.56102661.7561027 M 92.26102666.1761026 M
doi:10.1371/journal.pone.0002927.t002
Figure 5. Fluorescence emission spectra of ANS in the presence
and absence of aA-crystallin and the various dementia
associated peptides. The crystallin and the peptide concentration
used were 20 mM and 50 mM respectively. The samples were excited at
370 nm and emission scan was obtained from 400 to 600 nm.
doi:10.1371/journal.pone.0002927.g005
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monkey lens and oxidative stress has been shown to increase the
production of Ab precursor protein and Ab-40 peptide [28]. It was
demonstrated that Ab peptide has toxic effects on lens epithelial
cells [28]. Ab peptide was also shown to interact with aB-crystallin
[29,30].
Materials and Methods
Materials
Oxidized and reduced Danish dementia peptides (oxADan and
redADan), oxidized and reduced British dementia peptides
(oxABri and redABri), Ab-40 peptide were bought from Bachem
AG (Switzerland) and purified using a C-18 HPLC column in on a
WATERS HPLC. The purity and mass of the peptides were
assessed by MALDI-TOF mass spectrometer (Bruker Daltonics)
which were found to correspond to their expected masses of
4046.74 Da, 4044.52 Da, 3937.81 Da, 3939.88 Da and 4330.01
Da for redADan, oxADan, redABri, oxABri and Ab-40 peptides
respectively (Figure S4). The peptides were subjected to a HFIP
treatment as mentioned in [31] with a slight modification. Briefly,
the peptides were dissolved in HFIP (1, 1, 1, 3, 3, 3-hexafluoro-2-
propanol) and sonicated in a water bath for 1 hour, followed by
vortexing for 15 minutes. The solution was left in HFIP overnight.
The resulting solution was lyophilized and taken for fibrilization.
The lyophilized peptides thus obtained were dissolved in a
minimum volume of DMSO (dimethyl sulphoxide) under a flow
of liquid nitrogen. These were the stocks. In this way peptides
could be stored in DMSO for a period of almost a month without
any aggregation. Human HSP-70 was purchased from Sigma.
Purification of Recombinant aA- and aB-crystallins:
Expression vectors (pET23d) of human aA- and aB-crystallin
were a generous gift from Dr. J. Mark Petrash, Department of
Opthalmology and Visual Sciences (Washington University, St.
Louis, MO, USA). Human aA- and aB-crystallins were expressed
in bacterial (BL21) cells containing expression vectors (pET23d).
Proteins from 1-liter cultures were extracted and purified
according to the procedures described previously [25]. Briefly,
aA- and aB-crystallins were overexpressed in Escherichia coli BL21
cells containing the respective vectors by isopropyl 1-thio-b-D-
galactopyranoside induction and purified using MonoQ anion
exchange and Sephacryl S-300 gel filtration columns. The purity/
homogeneity of aA- and aB- crystallins was found to be 99% as
analyzed by SDS-PAGE. Concentrations of aA and aB crystallins
were calculated using molar extinction coefficients, (e280), of
16,500 and 19,000 M21 cm21, respectively.
Chaperone Activity Assay
The chaperone activities of aA-crystallin and aB-crystallin were
assessed by measuring each one’s ability to prevent the heat
induced aggregation of citrate synthase at 43uC and DTT-induced
aggregation of insulin at 25uC [25]. Apparent scattering of the
solution at 360 nm due to heat induced aggregation of citrate
synthase at 43uC at pH 7.9 (HEPES-KOH buffer), was monitored
as a function of time in the absence and presence of aA- or aB-
crystallins using a Jasco UV-visible spectrophotometer. The
amount of a-crystallins used was 5 mg/mL and the total volume
of the assay was 100 mL in 1 cm path length quartz cuvette. For
insulin aggregation assay the reaction was initiated by addition of
20 mM DTT in a solution containing 5 mg /ml aA-crystallin or
aB-crystallin and 0.2 mg/ml insulin at pH 7.2 in phosphate
buffer. The total volume of the reaction was kept to 100 ml.
Reactions were carried out at room temperature.
Assay for the chaperone activity with the human heat shock
protein HSP-70 was carried out as described in [27]. Its chaperone
activity was assayed by its ability to prevent thermal aggregation of
glutamate dehydrogenase (GDH). The assay mix comprised of
20 mM Tris buffer pH 7.4, 100 mM sodium chloride, 0.2 mg/ml
GDH and 0.2 mg/ml human HSP. The assay was carried out at
48uC using a peltier controlled cell and was monitored by
measuring the light scattering at 360 nm in a Jasco sphectrophot-
ometer. GDH was used in the assay to compare the results of this
study with those obtained in [27].
Determination of the binding constants of a-crystallins to
peptides.
The binding of aA-crystallin and aB-crystallin with Ab-40,
ADan and ABri peptides were assessed spectrophotometrically
using modification of the method detailed in [11]. In the absence
of crystallins all the peptides upon incubation at 25uC for 12 h are
found in the sediment upon centrifugation at 21,000 g for 30 min.
Crystallins keep them in solution under these conditions. Hence,
the ability of crystallins to keep the peptides in solution was used to
measure the affinity of their interactions with the peptides. Briefly,
2 mM of a-crystallins were incubated overnight (12 h) at 25uC with
different concentrations of the peptides spanning nanomolar to
millimolar concentration range in HEPES buffer (pH 7.8). In
another set of experiments a-crystallins were omitted and only the
peptides alone were incubated at these concentrations overnight at
25uC. Samples from both the sets were centrifuged at 21,000 g for
30 min and the supernatant and the precipitate were separated
out. The optical density of the supernatant fraction was taken at
215 nm. The difference in the absorbance before and after
centrifugation gives the amount of peptide aggregated. The
difference in the amount of peptide aggregated in the samples
with and without the crystallins gives the measure of the
association of crystallins with the peptides. The data were fitted
to the following equation:
y~
x
xz Kd
ð1Þ
Where, y is the difference in the amount of peptide associated with
a-crystallin and x is the concentration of the free peptide.
Lens organ culture:
Eyes were enucleated from 4 months old Wistar rats, obtained
from National Center for Laboratory Animal Services, National
Institute of Nutrition, Hyderabad immediately after sacrifice by
cervical dislocation. Animal care and protocols were in accordance
with and approved by Institutional Animal Ethics Committee.
Lenses were dissected from the eyes by anterior approach. Each
isolated lens was incubated in 2 ml of modified of TC-199 (Sigma)
medium with antibiotics. Osmolarity of the medium was adjusted
to 295 milli osmomoles using an osmometer (Micro Osmometer;
Model-210, Fiske Associates, Norwood, MA, USA). Lenses were
cultured as described previously [32,33]. Lenses were incubated at
37uC under 95% air and 5% CO2 in the absence or presence of
the various dementia associated peptides dissolved in DMSO for a
period of 96 h. All the reagents/chemicals used for lens organ
culture were filtered through 0.2 mm Millipore disc filters. Final
concentration of a given dementia associated peptides in the
culture medium was kept at 10 mM. Medium was changed every
24 h. At the end of incubation, lenses were kept on a grid (12/cm)
for assessing the transparency by placing them above a light
source.
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Extraction of proteins from the treated lenses
Lenses were homogenized in 10 vol. of 0.05 M Tris buffer
(pH 8.0), containing 0.1 M NaCl and 0.02% sodium azide. The
homogenate was centrifuged at 15 000 g for 30 min at 4uC and
the resulting supernatant was collected (soluble fraction). The
pellet was washed thrice and constituted in the same buffer
(insoluble fraction). Protein content in soluble and insoluble
fractions was estimated by Lowry’s method.
Purification and evaluation of the chaperone activity of a
-crystallin (aL-crystallin) isolated from peptide treated
lenses
a-Crystallins from the soluble fraction of the lens extract
described above (aL-crystallin) were purified by gel filtration on a
Sephacryl S-300 column ( 9060.62 cm) as described previously
[19]. Chaperone activity of the a L-crystallin thus isolated was
assayed using its ability to prevent aggregation of citrate synthase
undergoing heat inactivation at 43uC as described above.
ANS binding studies
ANS (1-anilino-8-naphthalene sulfonate) binding experiments
were executed with both the free a A-crystallin and its complexes
with the various dementia associated peptides. All the experiments
were done in a Jobin Yvon Horiba fluorometer (Jobin Yvon Spex,
Cedex, France) in a 1-cm path length quartz water- jacketed cell
using aA-crystallin and dementia associated peptides at concen-
trations of 20 mM and 50 mM respectively. The samples were
excited at 370 nm and emission scan was obtained from 400 to
600 nm.
Supporting Information
Figure S1 aB-crystallin demonstrated similar poisoning of
chaperone activity in the presence of the peptides as aA-crystallin.
The amount of aB-crystallin used was 10 mM. (a) Different
concentration ration of redADan peptide and aB-crystallin is used
and (b) All the dementia peptides are used (concentration of the
peptides 10 mM).
Found at: doi:10.1371/journal.pone.0002927.s001 (1.40 MB TIF)
Figure S2 Isothermal Calorimetric Curve of the titration of 20
mM of aA-crystallin assuming its relative molecular weight Mr
,20,000 with 250 mM of redADan peptide. (Upper panel) Raw
data of heat evolved during the titration. The first injection was
executed by injection of 2 mL of redADan solution in the cell. The
later injections were of 8 mL. (lower panel) Least squares fit of the
data in the upper panel for the determination of the thermody-
namic parameters of interaction. The value of Kb obtained from
nonlinear least squares minimization method is 0.66106.ITC was
performed by using VPITC calorimeter from Microcal Inc.
(Northampton, MA). aA-crystallin (,Mr 20,000 ), 20 mM in
1.5 ml 5 mM Hepes buffer (pH 7.8), was titrated with 8 ml of
redADan solution (250 mM) at an interval of 3 min using a syringe
rotating at 310 rpm. The data so obtained were fitted via
nonlinear least squares minimization method to determine binding
stoichiometry (n), binding constant (Kb), and change in enthalpy of
binding (delta H) using Origin software (Microcal). The experi-
mental conditions ensured that c was 12, where c =KbMt (0) and
Mt(0) is the initial macromolecular concentration. The value of the
binding constant (Kb) was used to compare the value obtained
spectroscopically.
Found at: doi:10.1371/journal.pone.0002927.s002 (1.22 MB TIF)
Figure S3 Chaperone activity of PfHSP-70 (0.2 mg/ml) as
assessed by the suppression of heat induced aggregation of GDH
at 48uC in the presence of different concentrations of redADan
peptides (GDH (0.2 mg/ml)).
Found at: doi:10.1371/journal.pone.0002927.s003 (0.89 MB TIF)
Figure S4 The MALDI mass spectrum of the HPLC purified
dementia peptides. (a) redADan (b) oxADan peptides. (c) redABri
(d) oxABri peptides and (e) Ab-40 peptides. The disaggregated
peptide solution were dissolved in water and after spinning, 0.5 mL
of this sample was spotted on MALDI plate followed by 0.5 mL of
alpha-cyano-4-hydroxycinnamic acid matrix (10 mg/mL in 50%
acetonitrile, 0.1% TFA). After drying the plate was inserted in the
voyager. All the spectra were collected in the positive ionization
mode.
Found at: doi:10.1371/journal.pone.0002927.s004 (1.25 MB TIF)
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